Matinas BioPharma sets 1-for-15 reverse stock split effective Sept. 28
MTNB•Reverse split details
Matinas BioPharma will consolidate its common stock in a 1-for-15 reverse split effective 12:01 a.m. ET on Sept. 28, 2026.
Shares are expected to trade on a split-adjusted basis on the NYSE American at the open on Sept. 28 under MTNB.
Fractional shares will not be issued; holders will receive cash in lieu of any fractional entitlement.
Post-split ownership percentages and voting power are expected to remain largely unchanged, aside from rounding effects.
The new CUSIP following the reverse split will be 576810 402.
